VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 132 filers reported holding VBI VACCINES INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,277 | -22.5% | 10,815 | 0.0% | 0.00% | – |
| Q4 2022 | $4,230 | -47.1% | 10,815 | 0.0% | 0.00% | – |
| Q3 2022 | $8,000 | -11.1% | 10,815 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -69.0% | 10,815 | -37.5% | 0.00% | – |
| Q1 2022 | $29,000 | -32.6% | 17,315 | -5.5% | 0.00% | -100.0% |
| Q4 2021 | $43,000 | -20.4% | 18,315 | +5.8% | 0.00% | 0.0% |
| Q3 2021 | $54,000 | -10.0% | 17,315 | -2.8% | 0.00% | 0.0% |
| Q2 2021 | $60,000 | +9.1% | 17,815 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $55,000 | +12.2% | 17,815 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $49,000 | -3.9% | 17,815 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $51,000 | -12.1% | 17,815 | -5.3% | 0.00% | -50.0% |
| Q2 2020 | $58,000 | +56.8% | 18,815 | -51.3% | 0.00% | +100.0% |
| Q1 2020 | $37,000 | -31.5% | 38,602 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $54,000 | +500.0% | 38,602 | +95.1% | 0.00% | – |
| Q3 2019 | $9,000 | -60.9% | 19,787 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $23,000 | – | 19,787 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |